TY - JOUR T1 - Pazopanib versus paclitaxel in relapsed urothelial tumors: A randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive transitional cell carcinoma of the urothelium (PLUTO). JO - Journal of Clinical Oncology PY - 2014/05/20 AU - Jones RJ AU - Chester JD AU - Dixon-Hughes J AU - Alexander L AU - Bahl A AU - Hussain SA AU - Birtle A AU - Jagdev S AU - Morris A AU - Stobo J AU - Bray CA et al ED - DO - DOI: 10.1200/jco.2014.32.15_suppl.tps4589 VL - 32 IS - 15_suppl SP - tps4589 EP - tps4589 Y2 - 2025/07/13 ER -